Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Substance Withdrawal Syndrome × salicylhydroxamic acid × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 2 Myocardial Reperfusion Injury 2 Cardiotoxicity 2 Vomiting 1 Uveal Melanoma 1 Thrombosis 1 Substance Withdrawal Syndrome 1 Retinal Diseases 1 Reperfusion Injury 1 Pain, Postoperative 1 Opioid-Related Disorders 1 Nausea 1 Melanoma 1 Macular Degeneration 1 Lymphoma, Follicular 1 Lung Neoplasms 1 Kidney Neoplasms 1 Head and Neck Neoplasms 1 Choroid Diseases 1 Breast Neoplasms 1

Interventions

salicylhydroxamic acid 1 nilotinib 1 morphine, naltrexone combination 1 Naltrexone 1 Morphine 1 Dasatinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04850664 2021-08-06

CBOT-OUD

Evon Medics LLC

Phase 2 Unknown

Lymphoma, Follicular, Opioid-Related Disorders, Substance Withdrawal Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡